Raynaud's phenomenon
Authors:
- PaulineM. DowdPDPaulineM. Dowd
- PortiaC. GoldsmithPGPortiaC. Goldsmith
- HelenA. BullHBHelenA. Bull
- Geoffrey BurnstockGBGeoffrey Burnstock
- JohnC. ForemanJFJohnC. Foreman
- Ian MarshallIMIan Marshall
- 1 July 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 346 (8970) , 283-290
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Integration of Factors Controlling Vascular ToneAnesthesiology, 1993
- Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenonThe Lancet, 1993
- Mechanism of Vascular Relaxation by the Calcitonin Gene‐Related PeptideaAnnals of the New York Academy of Sciences, 1992
- Image analysis quantification of peptide‐immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosisThe Journal of Pathology, 1991
- Digital Cutaneous Vascular Responses to Histamine and Neuropeptides in Raynaud's PhenomenonJournal of Investigative Dermatology, 1991
- Sympathetic noradrenergic neurons containing dynorphin but not neuropeptide Y innervate small cutaneous blood vessels of guinea-pigsJournal of the Autonomic Nervous System, 1990
- Serum From Patients With Raynaud's Phenomenon Inhibits Prostacyclin ProductionJournal of Investigative Dermatology, 1987
- Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processingNature, 1983
- Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)British Journal of Dermatology, 1982
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980